A double determination of central motor conduction time in the assessment of Hirayama disease

Hirayama disease (HD) is a benign neurological disease associated with unilateral or asymmetric weakness and/or amyotrophy in the muscles supplied by the C7-T1 myotomes, without significant sensory involvement and myelopathy (Hirayama, 2000; Zhou et al., 2010; Wang et al., 2012).

http://ift.tt/2wgnbKO